Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02960230
Title H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of California, San Francisco
Indications
Therapies
Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
Rady Children's Hospital-San Diego San Diego California 92123 United States Details
University of California, San Francisco San Francisco California 94158 United States Details
Children's National Medical Center Washington District of Columbia 20010 United States Details
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Children's Hospitals and Clinics of Minnesota Minneapolis Minnesota 55455 United States Details
St. Louis Children's Hospital Saint Louis Missouri 63110 United States Details
Nationwide Children's Hospital Columbus Ohio 43205 United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 United States Details
St. Jude Children's Research Hospital Memphis Tennessee 38105 United States Details
Texas Children's Hospital Houston Texas 77030 United States Details
University of Utah Salt Lake City Utah 84112 United States Details
Seattle Children's Hospital Seattle Washington 98105 United States Details
The University Children's Hospital in Zurich Zürich Zurich 8032 Switzerland Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field